Antenatal management of the thrombocytopenias Review uri icon

Overview

MeSH Major

  • Fetal Diseases
  • Thrombocytopenia

abstract

  • Thrombocytopenia, the most common hemostatic disease of the newborn, can now be safely identified and treated antenatally to prevent life-threatening fetal and neonatal hemorrhage. This article focuses on the fetal thrombocytopenias with emphasis on the most common causes, the immune thrombocytopenias, including alloimmune and autoimmune mechanisms. The clinical presentation and differential diagnosis are discussed briefly.

publication date

  • January 1994

Research

keywords

  • Review

Identity

Language

  • eng

PubMed ID

  • 7982336

Additional Document Info

start page

  • 591

end page

  • 614

volume

  • 21

number

  • 3